A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.046 SEK Market Closed
Market Cap: 121.3m SEK

Wall Street
Price Targets

ACTI Price Targets Summary
Active Biotech AB publ

Wall Street analysts forecast ACTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACTI is 0.263 SEK with a low forecast of 0.24 SEK and a high forecast of 0.292 SEK.

Lowest
Price Target
0.24 SEK
423% Upside
Average
Price Target
0.263 SEK
472% Upside
Highest
Price Target
0.292 SEK
534% Upside
Active Biotech AB publ Competitors:
Price Targets
1801
Innovent Biologics Inc
36% Upside
9926
Akeso Inc
53% Upside
AZT
Arcticzymes Technologies ASA
59% Upside
BVXP
Bioventix PLC
114% Upside
LTRN
Lantern Pharma Inc.
556% Upside
GRAL
Grail Inc
21% Upside
COYA
Coya Therapeutics Inc
190% Upside
BCRX
BioCryst Pharmaceuticals Inc
183% Upside

Revenue
Forecast

Revenue Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Active Biotech AB publ

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACTI's stock price target?
Price Target
0.263 SEK

According to Wall Street analysts, the average 1-year price target for ACTI is 0.263 SEK with a low forecast of 0.24 SEK and a high forecast of 0.292 SEK.

Back to Top